Attorneys for Plaintiffs and the Class
[Additional Attorneys listed on following page]
UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF CALIFORNIA
ROBERT PEREZ, NANCY ART and BRETT HARBACH, on behalf of themselves and all others similarly situated, Plaintiffs, vs. NIDEK CO. LTD.; NIDEK INCORPORATED; NIDEK TECHNOLOGIES INCORPORATED; MANOJ V. MOTWANI, M.D., GARY M. KAWESCH, M.D., LINDA VU, M.D., JOSEPH LEE, M.D., FARZAD YAGHOUTI, M.D., RANDA M. GARRANA, M.D., THOMAS S. TOOMA, M.D., PAUL C. LEE, M.D., KEITH LIANG, M.D., ANTOINE L. GARABET, M.D., WILLIAM ELLIS, M.D., GREGG FEINERMAN, M.D., MICHAEL ROSE, M.D., JOHN KOWNACKI, M.D., STEVEN MA, M.D., Estate of GLENN A. KAWESCH, M.D., TLC VISION CORPORATION also dba TLC LASER EYE CENTERS, INC.; CALIFORNIA CENTER FOR REFRACTIVE SURGERY, A MEDICAL CORPORATION; LASER EYE CENTER MEDICAL OFFICE INC.; SOUTHWEST EYE CARE CENTERS INC.; and DOES 1 through 1000, inclusive. Defendants. | ) | CASE NO. 3:08-CV-1261 BTM (JMA)
CLASS ACTION SECOND AMENDED CLASS ACTION COMPLAINT FOR: (1) VIOLATIONS OF HEALTH AND SAFETY CODE § 24176 (2) VIOLATIONS OF CIVIL CODE §1750, ET SEQ.; (3-5) VIOLATIONS OF BUSINESS AND PROFESSIONS CODE § 17200, ET SEQ.; AND (6) CIVIL CONSPIRACY |
James M. Lindsay, State Bar No. 164758
Gene J. Stonebarger, State Bar No. 209461
LINDSAY & STONEBARGER
A Professional Corporation
620 Coolidge Drive, Suite 225
Folsom, CA 95630
Tel: (916) 294-0002 Fax: (916) 294-0012
jlindsay@lindstonelaw.com
gstonebarger@lindstonelaw.com
James R. Patterson, State Bar No. 211102
Harry W. Harrison, State Bar No. 211141
HARRISON PATTERSON & O'CONNOR LLP
402 West Broadway, 29th Floor
San Diego, CA 92101
Tel: (619) 756-6990 Fax: (619) 756-6991
jpatterson@hpolaw.com
hharrison@hpolaw.com
Attorneys for Plaintiffs and the Class
Plaintiffs file this Class Action Complaint on behalf of themselves and all others similarly situated and by their attorneys allege upon information and belief the claims set forth herein against all defendants (collectively as "DEFENDANT PHYSICIANS & NIDEK"), based upon documentary evidence, the investigation of attorneys, the investigation of the Federal Food and Drug Administration("FDA"), and the federal Food, Drug, and Cosmetic Act ("the Act"), interviews and deposition transcripts of potential witnesses and persons knowledgeable of these events as follows: